TY  - BOOK
AU  - Giaccone,Giuseppe
TI  - Systemic Treatment of Non-Small Cell Lung Cancer
SN  - 9780191502392 (electronic bk.)
PY  - 2012///
PB  - Oxford University Press, USA
KW  - Lungs
KW  - Cancer
KW  - Treatment
N2  - Lung cancer is the leading cause of cancer mortality worldwide, and non-small cell lung cancer (NSCLC) accounts for about 85% of all cases of lung cancer. Most patients present with advanced disease and five-year survival is low at about 15%. Surgery is the main treatment for early stage disease. If patients are deemed inoperable, systemic chemotherapy is considered. For patients with locally advanced disease, multimodality therapy is administered where chemotherapy is given incombination with definitive radiation therapy or surgery in selected cases. Cytotoxic chemotherapy regimens mainly con
UR  - https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=678238
ER  -